Literature DB >> 34121201

ATP and cancer immunosurveillance.

Oliver Kepp1,2, Lucillia Bezu1,2, Takahiro Yamazaki3, Francesco Di Virgilio4, Mark J Smyth5, Guido Kroemer1,2,6,7,8, Lorenzo Galluzzi3,9,10,11,12.   

Abstract

While intracellular adenosine triphosphate (ATP) occupies a key position in the bioenergetic metabolism of all the cellular compartments that form the tumor microenvironment (TME), extracellular ATP operates as a potent signal transducer. The net effects of purinergic signaling on the biology of the TME depend not only on the specific receptors and cell types involved, but also on the activation status of cis- and trans-regulatory circuitries. As an additional layer of complexity, extracellular ATP is rapidly catabolized by ectonucleotidases, culminating in the accumulation of metabolites that mediate distinct biological effects. Here, we discuss the molecular and cellular mechanisms through which ATP and its degradation products influence cancer immunosurveillance, with a focus on therapeutically targetable circuitries.
© 2021 The Authors.

Entities:  

Keywords:  ADORA2A; CD39; CD73; autophagy; immune checkpoint inhibitors; immunogenic cell death

Mesh:

Substances:

Year:  2021        PMID: 34121201      PMCID: PMC8246257          DOI: 10.15252/embj.2021108130

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   14.012


  209 in total

Review 1.  Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors.

Authors:  Lorenzo Galluzzi; Juliette Humeau; Aitziber Buqué; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Clin Oncol       Date:  2020-08-05       Impact factor: 66.675

2.  Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy.

Authors:  Paul A Beavis; Melissa A Henderson; Lauren Giuffrida; Jane K Mills; Kevin Sek; Ryan S Cross; Alexander J Davenport; Liza B John; Sherly Mardiana; Clare Y Slaney; Ricky W Johnstone; Joseph A Trapani; John Stagg; Sherene Loi; Lev Kats; David Gyorki; Michael H Kershaw; Phillip K Darcy
Journal:  J Clin Invest       Date:  2017-02-06       Impact factor: 14.808

3.  CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer.

Authors:  Jieyao Li; Liping Wang; Xinfeng Chen; Lifeng Li; Yu Li; Yu Ping; Lan Huang; Dongli Yue; Zhen Zhang; Fei Wang; Feng Li; Li Yang; Jianmin Huang; Shuangning Yang; Hong Li; Xuan Zhao; Wenjie Dong; Yan Yan; Song Zhao; Bo Huang; Bin Zhang; Yi Zhang
Journal:  Oncoimmunology       Date:  2017-04-21       Impact factor: 8.110

4.  The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27.

Authors:  Sènan M d'Almeida; Gilles Kauffenstein; Charlotte Roy; Laetitia Basset; Loukas Papargyris; Daniel Henrion; Véronique Catros; Norbert Ifrah; Philippe Descamps; Anne Croue; Pascale Jeannin; Marc Grégoire; Yves Delneste; Julie Tabiasco
Journal:  Oncoimmunology       Date:  2016-04-28       Impact factor: 8.110

5.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

6.  Expression of autophagy and ER stress-related proteins in primary salivary adenoid cystic carcinoma.

Authors:  Licheng Jiang; Shengyun Huang; Wengang Li; Dongsheng Zhang; Shizhou Zhang; Weidong Zhang; Peihui Zheng; Zhanwei Chen
Journal:  Pathol Res Pract       Date:  2012-10-22       Impact factor: 3.250

7.  Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcome.

Authors:  Xianhuo Wang; Tingting Zhang; Zheng Song; Linyu Li; Xuhan Zhang; Jing Liu; Xianming Liu; Lihua Qiu; Zhengzi Qian; Shiyong Zhou; Lixia Feng; Ge Hu; Bin Meng; Qiongli Zhai; Xiubao Ren; Kai Fu; Lanfang Li; Ping Wang; Huilai Zhang
Journal:  Int J Cancer       Date:  2019-02-04       Impact factor: 7.396

8.  Connexin 43 Hemichannel Activity Promoted by Pro-Inflammatory Cytokines and High Glucose Alters Endothelial Cell Function.

Authors:  Juan C Sáez; Susana Contreras-Duarte; Gonzalo I Gómez; Valeria C Labra; Cristian A Santibañez; Rosario Gajardo-Gómez; Beatriz C Avendaño; Esteban F Díaz; Trinidad D Montero; Victoria Velarde; Juan A Orellana
Journal:  Front Immunol       Date:  2018-08-15       Impact factor: 7.561

9.  Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages.

Authors:  Stefan Bidula; Kshitija Dhuna; Ray Helliwell; Leanne Stokes
Journal:  Cell Death Dis       Date:  2019-11-25       Impact factor: 8.469

10.  Metabolites released from apoptotic cells act as tissue messengers.

Authors:  Parul Mehrotra; Sanja Arandjelovic; Justin S A Perry; Christopher B Medina; Yizhan Guo; Sho Morioka; Brady Barron; Scott F Walk; Bart Ghesquière; Alexander S Krupnick; Ulrike Lorenz; Kodi S Ravichandran
Journal:  Nature       Date:  2020-03-18       Impact factor: 49.962

View more
  25 in total

Review 1.  Immunogenic cell stress and death.

Authors:  Guido Kroemer; Lorenzo Galluzzi; Claudia Galassi; Laurence Zitvogel
Journal:  Nat Immunol       Date:  2022-02-10       Impact factor: 25.606

Review 2.  Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment.

Authors:  Giulia Petroni; Aitziber Buqué; Lisa M Coussens; Lorenzo Galluzzi
Journal:  Nat Rev Drug Discov       Date:  2022-03-15       Impact factor: 84.694

3.  A nanoparticle-based tour de force for enhancing immunogenic cell death elicited by photodynamic therapy.

Authors:  Oliver Kepp; Guido Kroemer
Journal:  Oncoimmunology       Date:  2022-07-08       Impact factor: 7.723

Review 4.  The multifaceted role of autophagy in cancer.

Authors:  Ryan C Russell; Kun-Liang Guan
Journal:  EMBO J       Date:  2022-05-10       Impact factor: 14.012

Review 5.  Cancer evolution: Darwin and beyond.

Authors:  Roberto Vendramin; Kevin Litchfield; Charles Swanton
Journal:  EMBO J       Date:  2021-08-30       Impact factor: 14.012

Review 6.  ArcRNAs and the formation of nuclear bodies.

Authors:  Shinichi Nakagawa; Tomohiro Yamazaki; Taro Mannen; Tetsuro Hirose
Journal:  Mamm Genome       Date:  2021-06-03       Impact factor: 2.957

Review 7.  Pannexin Channel Regulation of Cell Migration: Focus on Immune Cells.

Authors:  Paloma A Harcha; Tamara López-López; Adrián G Palacios; Pablo J Sáez
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

8.  Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation.

Authors:  Valentina Vultaggio-Poma; Simonetta Falzoni; Paola Chiozzi; Alba Clara Sarti; Elena Adinolfi; Anna Lisa Giuliani; Alejandro Sánchez-Melgar; Paola Boldrini; Michele Zanoni; Anna Tesei; Paolo Pinton; Francesco Di Virgilio
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 9.  ATP and cancer immunosurveillance.

Authors:  Oliver Kepp; Lucillia Bezu; Takahiro Yamazaki; Francesco Di Virgilio; Mark J Smyth; Guido Kroemer; Lorenzo Galluzzi
Journal:  EMBO J       Date:  2021-06-14       Impact factor: 14.012

10.  On the molecular, cellular and tissue origin of cancer.

Authors:  Elisabetta Argenzio; Daniel Klimmeck
Journal:  EMBO J       Date:  2021-07-21       Impact factor: 14.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.